非药物忧郁症治疗市场：现况分析与预测（2023-2030）

Drug Free Depression Treatment Market: Current Analysis and Forecast (2023-2030)

出版日期: 2024年02月01日 | 出版商:

UnivDatos Market Insights Pvt Ltd | 英文 145 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录

由于忧郁症患者数量的增加，非药物忧郁症治疗市场预计将以约10.1%的速度稳定成长。例如，根据世界卫生组织 (WHO) 的统计，估计有 3.8% 的人口患有忧郁症，其中包括 5% 的成年人（4% 男性和 6% 女性）和 5.7% 的 60 岁以上成年人。过忧郁症。在预测期内，有几个因素推动了市场的成长，例如焦虑病例的急剧增加、心理健康意识的提高以及对心理学部门的投资增加。除此之外，透过非药物忧郁症治疗提高治疗效率带来了有效的治疗程序，这也推动了非药物忧郁症治疗市场的稳定成长。

依治疗类型，市场分为认知行为疗法、经颅磁刺激、草药疗法等。由于对非药物忧郁症治疗的需求不断增加，认知行为治疗领域在2022年占全球非药物忧郁症治疗市场的最大占有率。例如，英国皇家精神病学家学院 2022 年 4 月分析的新数据显示，2021 年英国认知行为治疗 (CBT) 的年度预约人数创下了 1,961,096 人的历史新高。认知行为治疗（CBT）是一种心理治疗方法，重点在于思想、情绪和行为之间的连结。它旨在帮助个人识别并改变促使其问题的消极思维模式和行为。它通常是结构化的、以目标为导向的，并包括管理症状和改善整体健康的实用策略。因此，在治疗类型中，认知行为治疗领域将在2022年占重要的市场占有率。

依设施类型，市场分为医院、专科诊所和復健中心。由于忧郁症患者数量不断增加，康復中心细分市场在预测期内预计将占相当大的市场占有率。例如，根据世界卫生组织 (WHO) 发布的 2021 年科学概述，全球焦虑和忧郁的盛行率增加了 25%。復健中心是专门的设施，为从各种健康状况（包括忧郁症）中恢復的人们提供结构化的计划和治疗。这些中心提供全面的护理，以满足每个人的独特需求。因此，康復中心类别在预测期内预计将在设施类型中表现出较高的复合年增长率。

为了更瞭解非药物忧郁症治疗的市场介绍，市场为北美（美国、加拿大等北美地区）、欧洲（德国、英国、法国、西班牙、义大利等欧洲国家）地区）和亚洲。太平洋地区（中国、日本、印度和其他亚太地区）和世界其他地区的全球分布进行分析。由于人们对药物副作用的认识不断提高，以及引入创新的非药物忧郁症治疗方法的投资不断增加，北美在 2022 年目前的情况下将主导市场。随着忧郁症发病率的上升，政府机构在该地区启动了心理健康意识计画。例如，加拿大统计局 2023 年 9 月的一份报告发现，过去十年中，15 岁及以上患有重度忧郁症、躁郁症和广泛性焦虑症的加拿大人比例有所增加。因此，从地区来看，2022年北美将占较大的市场占有率。

Depression is a common and serious mood disorder that affects a person's feeling, thinking, and other daily activities. It can cause persistent feelings of sadness, hopelessness, and loss of interest in activities once a person enjoyed. Depression can interfere with their ability to function at work, school, or in daily life and can also lead to a variety of physical symptoms such as changes in appetite or sleep patterns, fatigue, and physical aches or pains. Drug-free depression treatment refers to approaches and therapies used to manage depression without the use of medication. People find relief from depression symptoms through alternative therapies such as acupuncture, massage therapy, herbal remedies, or relaxation techniques like progressive muscle relaxation or biofeedback which is leading to the growth of the market. Several other factors, such as rising research & development activities, rising healthcare expenditure, rising regulatory support, and a surge in government collaborations & partnerships are leading drivers of drug free depression treatment globally.

The Drug Free Depression Treatment Market is expected to grow at a steady rate of around 10.1% owing to the rising cases of depression. For instance, according to the World Health Organization, an estimated 3.8% of the population experience depression, including 5% of adults -4% among men and 6% among women, and 5.7% of adults older than 60 years. Several factors, including a surge in the incidence of anxiety cases, increasing awareness regarding mental health, and increased investments in psychology departments are driving the market's growth during the forecast period. Apart from this, accelerated treatment efficiency with drug free depression treatment has resulted in effective treatment procedures which are also driving this market of drug free depression treatment at a steady rate.

Based on the treatment type, the market is segmented into cognitive behavioural therapy, transcranial magnetic stimulation, herbal remedies, and others. The cognitive behavioural therapy segment held the maximum share in the global market of drug free depression treatment in 2022 owing to the rising demand for drug free depression treatment. For instance, in April 2022, new data analyzed by the Royal College of Psychiatrists showed a record number of 1,961,096 annual appointments for those accessing cognitive behavioral therapy (CBT) across England for the year 2021. Cognitive behavioral therapy (CBT) is a psychotherapy approach that focuses on the connections between thoughts, feelings, and behaviors. It aims to help individuals identify and change negative thought patterns and behaviors contributing to their problems. It's often structured, goal-oriented, and involves practical strategies for managing symptoms and improving overall well-being. Thus, among the treatment type, the cognitive behavioural therapy segment held a significant market share in 2022.

Based on facility type, the market is categorized into hospitals, specialized clinics, and rehabilitation centers. The rehabilitation centers segment is expected to hold a significant share of the market in the forecast period owing to the rising cases of depression. For instance, according to a scientific brief released by the World Health Organization (WHO) in the year 2021, the global prevalence of anxiety and depression increased by a massive 25%. Rehabilitation centers are specialized facilities that provide structured programs and therapies to individuals recovering from various health conditions, including depression. These centers offer comprehensive care tailored to meet the unique needs of each individual. Thus, the rehabilitation centers category is expected to witness a higher CAGR amongst facility types during the forecast period.

For a better understanding of the market adoption of drug free depression treatment, the market is analyzed based on its worldwide presence in countries such as North America (U.S., Canada, and the Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. North America is dominating the market in the current scenario of 2022 due to the rising awareness about the adverse effects of drugs, and the rising number of investments in introducing innovative drug free depression therapies. Government organizations are initiating mental health awareness programs for the sake of the growing rate of depression cases in the region. For instance, according to Statistics Canada's report in September 2023, the percentage of Canadians aged 15 years and older suffering from major depressive episodes, bipolar disorder, and generalized anxiety disorder has increased in the past 10 years. Thus, amongst regions, North America held a significant share of the market in 2022.

Some of the major players operating in the market include McLean Hospital; Great Oaks Recovery Center; Mayo Foundation for Medical Education and Research (MFMER); Fortis Healthcare; Cleveland Clinic; Craig Hospital; Select Medical Corporation; LHC Group, Inc.; Thomas Jefferson University Hospitals; NYU Langone Hospitals.

1. MARKET INTRODUCTION

1.1.Market Definitions
1.2.Main Objective
1.3.Stakeholders
1.4.Limitation

2. RESEARCH METHODOLOGY OR ASSUMPTION

2.1.Research Process of the Drug Free Depression Treatment Market
2.2.Research Methodology of the Drug Free Depression Treatment Market
2.3.Respondent Profile

3. MARKET SYNOPSIS

4. EXECUTIVE SUMMARY

5. IMPACT OF COVID-19 ON THE DRUG FREE DEPRESSION TREATMENT MARKET

6. DRUG FREE DEPRESSION TREATMENT MARKET REVENUE (USD BN), 2020-2030F

7. MARKET INSIGHTS BY TREATMENT TYPE

7.1.Cognitive Behavioural Therapy
7.2.Transcranial Magnetic Stimulation
7.3.Herbal Remedies
7.4.Others

8. MARKET INSIGHTS BY FACILITY TYPE

8.1.Hospitals
8.2.Specialized Clinics
8.3.Rehabilitation Centers

9. MARKET INSIGHTS BY REGION

9.1.North America
- 9.1.1.U.S.
- 9.1.2.Canada
- 9.1.3.Rest of North America
9.2.Europe
- 9.2.1.Germany
- 9.2.2.U.K.
- 9.2.3.France
- 9.2.4.Italy
- 9.2.5.Spain
- 9.2.6.Rest of Europe
9.3.Asia-Pacific
- 9.3.1.China
- 9.3.2.Japan
- 9.3.3.India
- 9.3.4.Rest of Asia-Pacific
9.4.Rest of World